Shares of GeoVax Labs Inc. (GOVX) are up over 8% at $3.62 in premarket trading, driven by renewed concerns about the monkeypox outbreak.
GeoVax is a clinical-stage biotechnology company focused on developing human vaccines for many of the world's most threatening infectious diseases and therapies for solid tumor cancers using novel proprietary platforms. Preclinical and research programs for preventive vaccines against Mpox and Smallpox, dubbed GEO-MVA, are also underway.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.